Search

everythinglearnresearchcommunity

for

Search:↓

High-dose ciclosporin significantly improved a young cat's severe skin condition.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

No treatment fully prevents hair loss from chemotherapy yet.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.